Pharma ad ban considerations, ‘most favored nation’ returns and Pinnacle live hit
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Pharma ad ban considerations, ‘most favored nation’ returns and Pinnacle live hit
-
ナレーター：
-
著者：
このコンテンツについて
Plenty of health policy changes were announced during the first five months of 2025 – however, many medical marketing industry stakeholders are focused on one policy proposal that hasn’t been unveiled yet: a ban on pharmaceutical advertising.
In this week’s episode, reporter Heerea Rikhraj speaks with CheckedUp CEO and 2024 MM+M Pinnacle Award honoree Dr. Richard Awdeh about the potential ban on pharma TV ads and its implications for healthcare communications.
For Trends, pharma editor Lecia Bushak and managing editor Jack O’Brien break down President Donald Trump’s decision to sign an executive order to enact the ‘most favored nation’ policy for pharmaceutical drug pricing.
And to wrap up, we have a live hit from last week’s Pinnacle Awards with honoree Leslie Koby from Argenx.
Check us out at: mmm-online.com
Follow us:
YouTube: @MMM-online
TikTok: @MMMnews
Instagram: @MMMnewsonline
Twitter/X: @MMMnews
LinkedIn: MM+M
To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.